Development and validation of machine learning models for predicting muscle-invasive bladder cancer

Comparative performance analysis with VI-RADS

Authors

DOI:

https://doi.org/10.5489/cuaj.9728

Keywords:

Bladder cancer, Muscle-invasive bladder cancer; machine learning, VI-RADS, Multiparametric mrı, Predictive modeling

Abstract

Introduction: We aimed to develop and validate machine learning (ML)-based predictive models for the preoperative differentiation of muscle-invasive bladder cancer (MIBC) from non-muscle-invasive bladder cancer (NMIBC) using routinely available clinical and laboratory data, and to compare their diagnostic performance with the multiparametric magnetic resonance imaging (mpMRI)-based Vesical Imaging-Reporting and Data System (VI-RADS).

Methods: A total of 26 demographic, clinical, and biochemical variables were used to develop supervised ML models. Logistic regression, random forest, support vector machine, XGBoost, and LightGBM algorithms were trained to predict pathologic muscle invasion. The dataset was randomly divided into training (80%) and independent test (20%) cohorts. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). The performance of ML models was compared with a VI-RADS-based logistic regression model using the DeLong test, and model calibration was assessed using Brier scores.

Results: A total of 428 patients were included, comprising 317 with NMIBC and 111 with MIBC. In the independent test cohort, both the VI-RADS–based logistic regression model and the LightGBM model demonstrated high discriminative performance, with AUC values of approximately 0.93. Among ML methods, LightGBM showed the best overall performance. SMOTE improved sensitivity in most models, while calibration remained acceptable. DeLong analysis showed no significant difference between the LightGBM and VI-RADS models (p=0.49).

Conclusions: ML models based on routinely available clinical and laboratory variables achieved high diagnostic accuracy for predicting MIBC. The LightGBM model demonstrated performance comparable to the VI-RADS-based approach in the independent validation cohort and may serve as a complementary tool for risk stratification, particularly in settings where access to mpMRI is limited.

Downloads

Download data is not yet available.

Author Biography

Akif Erbin, Basaksehir Cam Sakura City Hospital

 Assoc. Prof. Akif Erbin
Department of Urology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey 

Downloads

Published

2026-11-20

How to Cite

Akalin, B., Erbin, A., Nisli, O., & Canat, H. (2026). Development and validation of machine learning models for predicting muscle-invasive bladder cancer: Comparative performance analysis with VI-RADS. Canadian Urological Association Journal, 21(3). https://doi.org/10.5489/cuaj.9728

Issue

Section

Original Research